BWX Technologies (BWXT) is down 4.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely explanation is a mix of continued pressure after BWXT’s early-August earnings update and a recent analyst price-target cut, rather than a clearly identifiable new company-specific event today. This could be because investors are still digesting a quarter that included a small revenue shortfall versus expectations, even though profitability and full-year guidance improved.

Details:

  • BWXT reported second-quarter 2026 revenue of $901.6 million, with adjusted EPS of $1.07 and raised its full-year 2026 guidance for revenue, adjusted EBITDA, non-GAAP EPS, and free cash flow.
  • The same earnings update also highlighted the planned sale of BWXT’s medical business, a strategic shift that sharpens focus on defense and commercial nuclear markets but may have added near-term uncertainty around the business mix.
  • A recent analyst note lowered the stock’s price target to $202 from $212 while keeping a Hold rating, suggesting a more cautious stance after the quarter.
  • BWXT also filed a 10-Q amendment in August, but the filing stated it was only to add omitted inline XBRL data and did not change the underlying financial disclosures.
  • Sources:

    BWX Technologies, SEC, TipRanks

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $BWXT Insider Trading Activity

    BWXT Insider Trades

    $BWXT insiders have traded $BWXT stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

    Here’s a breakdown of recent trading of $BWXT stock by insiders over the last 6 months:

    • REX D GEVEDEN (President and CEO) has made 0 purchases and 4 sales selling 10,000 shares for an estimated $1,725,006.
    • GERHARD F BURBACH sold 1,983 shares for an estimated $413,676
    • KEVIN JAMES GORMAN (VP & Chief Accounting Officer) sold 1,344 shares for an estimated $288,574
    See also  Dow gains as investors weigh stronger quarterly results, cost cuts, and dividend support

    To track insider transactions, check out Quiver Quantitative’s insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    $BWXT Hedge Fund Activity

    We have seen 437 institutional investors add shares of $BWXT stock to their portfolio, and 429 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $BWXT Government Contracts

    We have seen $132,268,823 of award payments to $BWXT over the last year.

    See also  Restaurant Brands International Gains as Strong Burger King Trends Continue to Support Sentiment

    Here are some of the awards which we have have seen pay out the most over the last year:

    To track government contracts to publicy traded companies, check out Quiver Quantitative’s government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

    $BWXT Congressional Stock Trading

    Members of Congress have traded $BWXT stock 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $BWXT stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative’s congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

    $BWXT Analyst Ratings

    Wall Street analysts have issued reports on $BWXT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Deutsche Bank issued a “Buy” rating on 05/15/2026

    To track analyst ratings and price targets for $BWXT, check out Quiver Quantitative’s $BWXT forecast page.

    $BWXT Price Targets

    Multiple analysts have issued price targets for $BWXT recently. We have seen 6 analysts offer price targets for $BWXT in the last 6 months, with a median target of $232.5.

    Here are some recent targets:

    • Scott Deuschle from Deutsche Bank set a target price of $255.0 on 05/15/2026
    • Alexandra Mandery from Truist Securities set a target price of $212.0 on 05/11/2026
    • David Strauss from Wells Fargo set a target price of $200.0 on 04/01/2026
    • Ronald Epstein from B of A Securities set a target price of $250.0 on 03/25/2026
    • Marc Bianchi from TD Securities set a target price of $230.0 on 03/12/2026
    • Andre Madrid from BTIG set a target price of $235.0 on 02/26/2026
    See also  CAVA Stock: Buy or Sell?

    This article is not financial advice. See Quiver Quantitative’s disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.


    Source link

    Author

    Shin John
    Shin JohnYtv Market News
    Share-market news writer and analyst with deep experience covering equities, commodities, forex, and cryptocurrencies for readers in the USA, UK, Canada, and Australia. Ytv Market News delivers timely market updates, practical trading insights, and clear explanations of macro and company-level catalysts that move prices. Combines on-the-ground financial reporting with technical analysis, using concise charts and actionable ideas to help investors and traders make smarter decisions.